Contact
Subscribe
COMPANY
About
Management
Directors
Scientific Advisory Board
Company Information
Careers
TECHNOLOGY
Overview
How It Works
Publications
APPLICATIONS
Markets
COVID-19 + Pandemics
Veterinary Diagnostics
Food Safety
INVESTORS
Stock Information
Share Structure
Financials
News
Media
Analyst Coverage
Product Info
Presentations
NEWS
News Releases
Events
MEDIA & RESOURCES
Media Coverage
Videos
Presentations
All Resources
COMPANY
About
Management
Directors
Scientific Advisory Board
Company Information
Careers
TECHNOLOGY
Overview
How It Works
Publications
APPLICATIONS
Markets
COVID-19 + Pandemics
Veterinary Diagnostics
Food Safety
INVESTORS
Stock Information
Share Structure
Financials
News
Media
Analyst Coverage
Product Info
Presentations
NEWS
News Releases
Events
MEDIA & RESOURCES
Media Coverage
Videos
Presentations
All Resources
OTCQB:LXXGF TSX.V:LXG
Company |
News Releases
November 13, 2019
LexaGene Provides Corporate Update
October 29, 2019
LexaGene Closes C$6.64 Million Financing
September 19, 2019
Successful Results Reported from Human Clinical Diagnostics Laboratory Beta Site
September 17, 2019
LexaGene Develops Test for Deadly Mosquito-borne EEE Virus
September 12, 2019
LexaGene Announces Second Cannabis Testing Laboratory Beta Test Site
September 5, 2019
LexaGene Reports on Beta Results from Cannabis-Focused Testing Laboratory
August 8, 2019
LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory
July 30, 2019
LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples
July 17, 2019
LexaGene Files Three Additional US Patents Covering Technology
July 10, 2019
Beta Testing Results at Mass Vet
June 6, 2019
LexaGene Hosts Investor Webinar
June 5, 2019
LexaGene Places its First Beta Prototype into Veterinary Hospital
‹
1
2
3
4
›
»
